Forest Laboratories Inc - Articles and news items

Actavis logo

Actavis plc appoints new members and announces changes to Board of Directors following close of Forest Laboratories, Inc. acquisition

Industry news / 2 July 2014 / Actavis

Actavis plc announced the appointment of three new members to the Company’s Board of Directors, including Actavis’ newly appointed CEO and President, Brenton L. Saunders…


AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam

Industry news, News / 18 October 2011 / AstraZeneca

ceftazidime/avibactam (CAZ-AVI) will enter phase III trials…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...